more interest in abuse-deterrent opioid formulations

You'll see more interest in abuse-deterrent opioid formulations.

This is stemming from the controversy surrounding the new long-acting hydrocodone med, Zohydro ER. It's NOT an abuse-deterrent form...despite concerns about its abuse potential.

Abuse-deterrent formulations aren't required by FDA yet...but are being promoted in an effort to reduce prescription opioid abuse.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote